Statins and hepatitis C virus: Friend or foe?

Hepatology

Volumn 51, Issue 1, 2010, Pages 352-

  Emanuele, Enzo ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPACTIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; SIMVASTATIN;

DRUG EFFECT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LETTER; MIXED INFECTION; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION;

FATTY ACIDS, MONOUNSATURATED; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDOLES; RNA, VIRAL;

EID: 73449104713     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23087     Document Type: Letter

References (5)

1. Delang L, Paeshuyse J, Vliegen I, Leyssen P, Obeid S, Durantel D, et al. Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development. HEPATOLOGY 2009; 22916.
2. Bader T, Fazili J, Madhoun M, Aston C, Hughes D, Rizvi S, et al. Fluvastatin inhibits hepatitis C replication in humans. Am J Gastroenterol 2008;103:1383-1389.
3. Shafiq N, Malhotra S, Pandhi P, Grover A. The "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst. J Negat Results Biomed 2005;4:3.
4. Milazzo L, Meroni L, Galazzi M, Cesari M, Caramma I, Marchetti G, et al. Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV coinfected patients. J Viral Hepat 2009; doi:10.1111/j.1365-2893.2009.01104.x.
5. Anfossi G, Massucco P, Bonomo K, Trovati M. Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits. Nutr Metab Cardiovasc Dis 2004;14:215-224.